Research & News

Weiss Ratings Daily
This shelter at home stuff is getting old. Just like you, I’ve been cooped up in my home and I am getting pretty antsy. Thank goodness for online shopping. I’ve been able to order groceries,...
Strategic Options Subscription Alert
Stocks are falling again Friday as investors fret about the possible revival of trade tensions between the U.S. and China over the COVID-19 pandemic. This puts the market on course to finish the...
Wealth Megatrends Subscription Alert
The markets are wobbling today after President Trump threatened retaliation on China over the coronavirus pandemic. This market hasn’t traded on fundamentals for a while, so it’s easy for...
Weekend Windfalls Subscription Your Issue
We’ve reached a very interesting crossroads in the markets … The averages have soared off the March lows thanks to aggressive Federal Reserve and Treasury Department activism: Enormous...
Strategic Options Subscription Your Issue
Stocks shoved into reverse on Thursday following a report about steeper U.S. job losses and a growing sense of doom about authorities’ efforts to control the spread of coronavirus. The Dow...
Strategic Options Subscription Alert
Stocks are retreating Thursday following another report about further job losses for Americans due to the COVID-19 pandemic. Through 2:45 p.m. Eastern, the Dow was down 335 points, or 1.4%,...
Supercycle Investor Subscription Alert
Earlier this week, I recommended two new trades — buying shares of First Majestic Silver (NYSE: AG) and September call options on Pfizer (NYSE: PFE). You were filled on First Majestic, and the...
Strategic Options Subscription Your Issue
* * * Note: I might not publish on Friday, so don’t be alarmed if the next letter arrives Monday morning. * * * Stocks ripped higher again Wednesday as investors applauded upbeat data from a...
Weiss Ratings Daily
First, the junk bond market boomed. Next, it went bust. Then, the Federal Reserve bailed it out. Finally, that sparked a new mini boom. More than anything else in recent weeks, THAT...
Strategic Options Subscription Alert
Stocks are ripping higher today as investors applaud upbeat data from a clinical trial of a potential COVID-19 treatment. The Dow Jones Industrials shot up 560 points, or 2.4%, through 2:30 p.m....